UTI 25hundred million won · Lycom 200hundred million won convertible bond disclosure

UTI and Lycom disclosed convertible bond issuances in succession. As convertible bonds may potentially be converted into new shares in the future, they can directly affect the number of shares held and the share price.

UTI disclosed the issuance of convertible bonds worth 2026year 7month 7day, the 7th 25hundred million won. The company included basic details such as the issuance name and amount in the disclosure.

The conversion price was set at 4,795won, and the conversion exercise period was disclosed as running from 2027year 7month 15day to 7month 20day. Specific terms, including the conversion price and exercise period, are stated in the disclosure.

Lycom 2026year 7month 8day, the 2th 200convertible bond issuance worth billion won. The issuance size and series number are stated in the disclosure.

Lycom’s conversion price is 5,788won, and the conversion request period is stated as running from 2027year 7month 16day through 7month 20day. Detailed terms, including the interest rate, maturity, and restrictions on eligible parties, are set out in each company’s original disclosure.

The conversion price refers to the price per share at the time of conversion. Once the conversion request period begins, bondholders may apply for conversion. Investors should check the original disclosure to review their holdings and trading plans.